Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Critical Reviews™ in Immunology
Factor de Impacto: 1.404 Factor de Impacto de 5 años: 3.347 SJR: 0.706 SNIP: 0.55 CiteScore™: 2.19

ISSN Imprimir: 1040-8401
ISSN En Línea: 2162-6472

Volumen 40, 2020 Volumen 39, 2019 Volumen 38, 2018 Volumen 37, 2017 Volumen 36, 2016 Volumen 35, 2015 Volumen 34, 2014 Volumen 33, 2013 Volumen 32, 2012 Volumen 31, 2011 Volumen 30, 2010 Volumen 29, 2009 Volumen 28, 2008 Volumen 27, 2007 Volumen 26, 2006 Volumen 25, 2005 Volumen 24, 2004 Volumen 23, 2003 Volumen 22, 2002 Volumen 21, 2001 Volumen 20, 2000 Volumen 19, 1999 Volumen 18, 1998 Volumen 17, 1997 Volumen 16, 1996 Volumen 15, 1995 Volumen 14, 1994

Critical Reviews™ in Immunology

DOI: 10.1615/CritRevImmunol.v35.i5.10
pages 349-364

Acquisition and Presentation of Tumor Antigens by Dendritic Cells

Irene Bonaccorsi
Laboratory of Immunology and Biotherapy, Department of Human Pathology, University of Messina, Messina, Italy
Stefania Campana
Laboratory of Immunology and Biotherapy, Department of Human Pathology, University of Messina, Messina, Italy
Barbara Morandi
Department of Experimental Medicine (DIMES), University of Genova, Genoa, Italy; Center of excellence in Biomedical Research, Centro di Eccellenza perla Ricerca Biomedica (CEBR), University of Genova, Genoa, Italy
Guido Ferlazzo
Laboratory of Immunology and Biotherapy, Department of Human Pathology, University of Messina, Messina, Italy; Cell Therapy Program, Azienda Ospedaliera Universitaria Policlinico "Gaetano Martino", Messina, Italy


Dendritic cells (DCs) are master regulators of the immune response and, because of their peculiar features in antigen acquisition, processing, and presentation, they play a critical role in activating an efficient antigenspecific T-lymphocyte response against tumors. However, the DC family is composed of different cell subsets, which may differently contribute to tumor-specific T-cell activation. In addition to the DC subset involved, the induction of a tumor-specific adaptive immune response is also dependent on DC interactions with other innate cell effectors, such as natural killer cells. The different modalities by which DCs can acquire tumor antigens also significantly affect antigen presentation because, in addition to the presentation of tumor antigens on MHC class II upon the classical exogenous antigen processing pathway, DCs are equipped to directly activate cytotoxic T cells via both cross-priming and cross-dressing. Here, the different forms of tumor antigen presentation by DCs are reviewed and discussed. We also discuss the ways in which this novel information could be exploited in the design of DC-based cancer vaccines.

Articles with similar content:

CD1d-Mediated Antigen Presentation to Natural Killer T (NKT) Cells
Critical Reviews™ in Immunology, Vol.23, 2003, issue 5-6
Tonya J. Roberts, Venkataraman Sriram, Yinling Lin, Sungyoo Cho, Randy R. Brutkiewicz, Yu Kyeong Hwang
Antigen-Specific B-Lymphocyte Activation
Critical Reviews™ in Immunology, Vol.23, 2003, issue 3
Gail A. Bishop, Sokol A. Haxhinasto, Bruce S. Hostager, Laura L. Stunz
Central and Effector Memory CD4 and CD8 T-Cell Responses to Tumor-Associated Antigens
Critical Reviews™ in Immunology, Vol.32, 2012, issue 2
Stefano Caserta, Jessica Geraldine Borger, Rose Zamoyska
Sensing Self and Non-Self DNA by Innate Immune Receptors and Their Signaling Pathways
Critical Reviews™ in Immunology, Vol.38, 2018, issue 4
Taro Kawai, Noor Hasima Nagoor, Sophia P. M. Sok, Daisuke Ori
CD28-CD80/86 and CD40-CD40L Interactions Promote Thymic Tolerance by Regulating Medullary Epithelial Cell and Thymocyte Development
Critical Reviews™ in Immunology, Vol.35, 2015, issue 1
Xuguang Tai , Richard J. Hodes, Joy A. Williams